Status:
COMPLETED
Testing Strategies to Improving Warfarin Adherence
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
Aetna, Inc.
Conditions:
Atrial Fibrillation
Deep Venous Thrombosis
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
We are performing a research study to learn more about the control of an individual's blood thinning (anticoagulation) on warfarin. Individuals from an anticoagulation clinic are being asked to partic...
Eligibility Criteria
Inclusion
- 21 years old age or older
- On warfarin managed at the AC clinic
- Target INR 2.0-3.0 or 2.5-3.5
- At maintenance phase of therapy (defined as stable INR with stable warfarin dosing over at least 2 consecutive visits)
Exclusion
- Do not have access to telephone line
- Unwillingness to participate or to sign a consent form(refusal)
- Inability to participate because of advances dementia, advanced Alzheimer's disease or other impairment affecting ability to provide informed consent and/or quality data or utilize the Med-eMonitor
- Participation in a current study that does not permit participation in another study
- End stage or terminal illness with anticipated life expectancy of 6 months or less
- INR over the upper limit for the individual's range at the time of enrollment (e.g.,\>3.0 or \>3.5, depending on the target range)
- Diagnosed with antiphospholipid antibody syndrome or abnormal INR prior to starting warfarin
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT00622102
Start Date
December 1 2007
End Date
April 1 2009
Last Update
December 2 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of the University of Pennsylvania Anticoagulation Management Center
Philadelphia, Pennsylvania, United States, 19104